tiprankstipranks

National Cancer Institute Investment Portfolio

The National Cancer Institute (NCI) is part of the U.S. National Institutes of Health and serves as the federal government's principal agency for cancer research and training. NCI supports development of cancer therapies, diagnostics, and technologies through grants, contracts, SBIR/STTR awards, Cooperative Research and Development Agreements (CRADAs), and collaborative programs with academic and private-sector entities.

Companies Invested In

Company Name
Sector
Investment Round Value
Funding Round
Announcement Date
PC:MPATHmPATH Health
Healthcare, Biotechnology & Medical Devices
$3.00M
Investment
Aug 14, 2025
PC:VIVERVivere Oncotherapies
Healthcare, Biotechnology & Medical Devices
$10.00M
Investment
Jan 13, 2026